Post job

AGC Biologics CEO and executives

Executive Summary. Based on our data team's research, Patricio E. Massera is the AGC Biologics's CEO. AGC Biologics has 2,151 employees, of which 10 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The AGC Biologics executive team is 20% female and 80% male.
  • 41% of the management team is White.
  • 13% of AGC Biologics management is Hispanic or Latino.
  • 8% of the management team is Black or African American.
Work at AGC Biologics?
Share your experience

Rate AGC Biologics' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Patricio E. Massera

Chief Executive Officer

Patricio E. Massera's LinkedIn

Patricio Massera was appointed Chief Executive Officer of AGC Biologics (formerly CMC Biologics) in May 2019. Patricio joined the company in 2012, as General Manager of Copenhagen-based CMC Biologics A/S. He later served as Chief Operating Officer in the Seattle-based company headquarters. As CEO, Patricio quickly developed a comprehensive people management strategy, recognizing that with a healthy company culture and highly engaged employees, AGC is best positioned to provide the highest-quality services to our customers. Across his 20 years of biologics experience, Patricio held several key executive positions at MSD AH, Intervet/Schering-Plough, Biogenesis-Bagó and other biotech companies in Spain, Brazil, and Argentina. With a background in biochemistry and business, Patricio has acted as a change agent in several integration processes and cultivated strong leadership teams, dedicated to developing, manufacturing, and controlling biotechnological products and vaccines for human and animal health.

Patricio holds an MBA from UCEMA and a Biochemist degree from the University of Buenos Aires.

Mads Laustsen

Founder

Vijay Raghavan

Chief Financial Officer

Vijay Raghavan became the Chief Financial Officer for AGC Biologics in January 2020. Vijay joined the company as Senior Vice President of Global Finance in April 2018, and has been a dedicated member and leader of the team, driving organizational growth through strategic financial planning, treasury, reporting and accounting. As CFO, Vijay continues to build value for the company, ensuring that AGC Biologics optimizes resource use to support the health and growth of our company and our customers. Vijay joined AGC Biologics after several years working in finance leadership roles at Cray and Microsoft. He leverages his 25 years of progressive experience in accounting, finance, business partnerships, strategic planning, and reporting for companies ranging from startups to conglomerates.

Outside of work, Vijay is dedicated to community service, including leadership positions at Hopelink and the Indian Association of Western Washington. Vijay earned a Masters of Commerce, Accounting, and Banking from the University of Madras in India, and an M.B.A. from the University of Hartford.

Mark W. Womack

Chief Business Officer

Mark W. Womack's LinkedIn

Over 25 years of successful experience leading large-scale business integrations and transformations of Fortune 200 client companies both as the COO of several international management consultancies, as well as with my own management and leadership consultancy corporation.

Currently a member of AGC Biologics' Global Executive Leadership Team, in the role of Chief Business Officer. In this role, I'm responsible for shaping, leading and growing our global business development program, capabilities and infrastructure across the US, Europe and Asia, in line with our vision and long-term strategy.



At AGC Biologics, we provide differentiated value to the world’s pharmaceutical companies as a leading global Contract Development and Manufacturing Organization.

Have been quoted as a key source in business articles in The New York Times and Fast Company and have been the keynote speaker at numerous major industry events in North America, Europe and Latin America.

Specialties:

- Large-scale business transformation and integration

- Client Business Development and Strategic Account Development

- Restructuring / Organization design and implementation

- Visioning

- Strategy definition and execution

- Brand definition and implementation

- Process and execution excellence

- Executive team development

- Executive leader development

Paul Tsang

Executive Vice President

Daisy Szabo

Executive Vice President

Hiroshi Nishimura

Senior Vice President

Kasper Møller

Chief Technical Officer

Patricio Era

CEO

Patricio Era's LinkedIn

Stina Andersen

Senior Executive Assistant To Global Chief Technical Officer

Stina Andersen's LinkedIn

Customer Experience Management | Public Relations | External and Internal Communication Recognized for co-leading global corporate and customer initiativesHighly skilled in content messaging and developing and directing organizational strategyFosters collaboration across global teams

Do you work at AGC Biologics?

Does leadership effectively guide AGC Biologics toward its goals?

AGC Biologics jobs

AGC Biologics founders

Name & TitleBio
Mads Laustsen

Founder

AGC Biologics leadership demographics

AGC Biologics gender distribution in management team

  • The AGC Biologics executive team is 20% female and 80% male.
  • AGC Biologics is 34% female and 66% male company-wide.
Male
Male
80%
Company-wide: 66%
Female
Female
20%
Company-wide: 34%

AGC Biologics executives by race

Management Team:
  • The most common ethnicity among AGC Biologics executive officers is White.
  • 41% of the management team is White.
  • 35% of AGC Biologics's management is Asian.
  • 13% of the management team is Hispanic or Latino.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 58% of employees are White.
  • 22% of employees are Asian.
  • 12% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

AGC Biologics jobs nearby

AGC Biologics executives FAQs

Zippia gives an in-depth look into the details of AGC Biologics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about AGC Biologics. The employee data is based on information from people who have self-reported their past or current employments at AGC Biologics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by AGC Biologics. The data presented on this page does not represent the view of AGC Biologics and its employees or that of Zippia.

AGC Biologics may also be known as or be related to AGC Biologics, AGC Biologics, Inc. and Cmc Biologics.